Thyroid Carcinoma

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib

CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma

Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy

Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Study of IK-595 in RAS- or RAF-altered Advanced Tumors

Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

More Than 50% of Unifocal cN0 T1b/Small T2 Papillary Thyroid Carcinoma May Require Completion Thyroidectomy if Nodal Status is Evaluated

An International Study on Pediatric Patients With Rare Tumors.

Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study

The Application of Electrical Stimulation in Postoperative Pain Management of Thyroid Surgery

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas

International PPB/DICER1 Registry

Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW